MedTrace Logo

Surgical Treatment of Peri-implantitis

NCT03163602 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-08-05

No results posted yet for this study

Summary

The aim of this randomized controlled study is to evaluate the outcome of surgical treatment of peri-implantitis with and without the use of a bone substitute graft covered by a collagen membrane. There will be a follow up period of 12 months. Outcome measures will include assessments of inflammation, probing depth, recession, radiological parameters and PROMs.

Conditions

  • Peri-Implantitis

Interventions

DRUG

Control group

Access flap and debridement

DEVICE

Test group

Regenerative treatment

Sponsors & Collaborators

  • Osteology Foundation

    collaborator OTHER

  • The University of Western Australia

    lead OTHER

Principal Investigators

  • Lisa Heitz-Mayfield, OdontDr · The University of Western Australia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-15
Primary Completion
2021-09-06
Completion
2021-09-06

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03163602 on ClinicalTrials.gov